Eleven Biotherapeutics CEO Thomas Cannell's 2022 pay falls 72% to $1.4M
Eleven Biotherapeutics reports 2022 executive compensation
By ExecPay News
Published: April 28, 2023
Eleven Biotherapeutics reported fiscal year 2022 executive compensation information on April 28, 2023.
In 2022, three executives at Eleven Biotherapeutics received on average a compensation package of $991K, a 63% decrease compared to previous year.
Thomas R. Cannell, Chief Executive Officer, received $1.4M in total, which decreased by 72% compared to 2021. 58% of Cannell's compensation, or $814K, was in stock awards. Cannell also received $577K in salary and $4K in other compensation.
Monica Forbes, Chief Financial Officer, received a compensation package of $889K, which decreased by 53% compared to previous year. 55% of the compensation package, or $485K, was in stock awards.
Mark Sullivan, General Counsel, earned $690K in 2022.